9 unknown, 6 completed, 5 recruiting, 3 active not recruiting. 11 Phase 2, 9 Phase 1, 4 Phase 3, 1 Not applicable.
Follow Advanced Gastric Carcinoma: new trials by email Literature Review of Advanced Gastric Carcinoma trials Research Report on Advanced Gastric Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer Docetaxel, Oxaliplatin, Leucovorin - Gastric Cancer, Stomach Cancer | Phase 2 / Phase 3 | Recruiting | Ukrainian Society of Clinical Oncology | 150 | 2025-03-25 | 2025-05-06 |
| SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer SHR-A1811 & Apartinib - Advanced Gastric Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | Phase 2 | Not yet recruiting | Yunpeng Liu | 28 | 2024-12-01 | 2024-10-30 |
| A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors NKT3964, Paclitaxel, Doxorubicin - Solid Tumor, Advanced Solid Tumor | Phase 1 | Recruiting | NiKang Therapeutics, Inc. | 238 | 2024-09-19 | 2026-10-30 |
| Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer. Peripheral blood, tougue coating, saliva, and feces - Advanced Gastric Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | Unknown | Xiangdong Cheng | 150 | 2024-03-25 | 2024-10-15 | |
| A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors NKT3447 - Solid Tumor, Solid Tumor, Adult | Phase 1 | Terminated | NiKang Therapeutics, Inc. | 23 | 2024-02-23 | 2025-09-25 |
| At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment - Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 220 | 2023-08-23 | 2026-04-20 |
| Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T Claudin18.2 CAR-T cells - Advanced Pancreatic Carcinoma, Advanced Gastric Carcinoma | Not applicable | Recruiting | Shenzhen University General Hospital | 20 | 2022-10-01 | 2022-11-22 |
| RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer RC48+AK105+cisplatin - Advanced Gastric Carcinoma, HER2-positive Gastric Cancer | Phase 2 | Unknown | Henan Cancer Hospital | 40 | 2022-05-07 | 2022-04-06 |
| Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC) Ferinject, Conservative management - Advanced Gastric Carcinoma | Phase 3 | Recruiting | Asan Medical Center | 330 | 2022-04-29 | 2026-04-03 |
| The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Gastric Cancer PDO group, Traditional group - Advanced Gastric Carcinoma | Unknown | Shanghai Minimally Invasive Surgery Center | 54 | 2022-04-01 | 2022-04-28 | |
| Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma radical surgery after neoadjuvant immunotherapy, radical surgery after neoadjuvant chemotherapy - Advanced Gastric Carcinoma, CD8+ Tumor Infiltrating Lymphocytes | Phase 3 | Not yet recruiting | Fujian Medical University | 120 | 2022-03-01 | 2022-03-08 |
| IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 IMM2902 - Advanced Solid Tumor, Advanced Lung Cancer | Phase 1 / Phase 2 | Unknown | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 105 | 2022-02-15 | 2023-04-10 |
| Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients Lenvatinib - First-line Treatment, Advanced Gastric Carcinoma | Phase 1 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 18 | 2021-11-01 | 2022-02-03 |
| iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Irinotecan, Oxaliplatin, TAS 102 (Trifluridine/Tipiracil) - Gastroesophageal Junction Adenocarcinoma, Advanced Gastric Carcinoma | Phase 2 | Completed | AHS Cancer Control Alberta | 7 | 2021-10-27 | 2024-06-14 |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer Cisplatin, Elimusertib, Gemcitabine Hydrochloride - Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 74 | 2021-08-25 | 2026-07-31 |
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing - Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 10 | 2021-08-13 | 2026-08-21 |
| Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial Biopsy Procedure, Biospecimen Collection, Ceralasertib - Advanced Breast Carcinoma, Advanced Colon Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 51 | 2021-08-09 | 2026-09-04 |
| Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma camrelizumab, Apatinib Mesylate - Advanced Gastric Carcinoma | Phase 2 | Unknown | Henan Cancer Hospital | 20 | 2021-04-28 | 2021-07-01 |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric Carcinoma Mitoxantrone Hydrochloride Liposome, intravenous injection - Advanced Gastric Carcinoma | Phase 1 | Terminated | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 21 | 2021-03-30 | 2024-03-07 |
| Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST) Atezolizumab + Ipatasertib, Atezolizumab + Bevacizumab - Gastric Adenocarcinoma, Metastatic Gastric Cancer | Phase 2 | Completed | Hospices Civils de Lyon | 54 | 2021-03-19 | 2026-06-09 |
Showing 20 of 27. Sign in to see all of them.
Stomach Neoplasms (6) · Endometrial Neoplasms (3) · Neoplasm Metastasis (3) · Ovarian Neoplasms (3) · Triple Negative Breast Neoplasms (3) · Colorectal Neoplasms (2) · Small Cell Lung Carcinoma (2) · Uterine Diseases (2) · Adenocarcinoma (1) · Anastomotic Leak (1) · Breast Neoplasms (1) · Carcinosarcoma (1) · Colonic Neoplasms (1) · Gastrointestinal Neoplasms (1) · Lung Neoplasms (1)
Neoplasms (7) · Neoplasms by Site (7) · Digestive System Diseases (6) · Digestive System Neoplasms (6) · Gastrointestinal Diseases (6) · Stomach Diseases (6) · Gastrointestinal Neoplasms (5) · Breast Diseases (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Genital Neoplasms, Female (4) · Neoplasms by Histologic Type (4) · Pathologic Processes (4)
Oxaliplatin (4) · BAY 1895344 (2) · Biopsy (2) · Capecitabine (2) · Fluorouracil (2) · Irinotecan (2) · Leucovorin (2) · Specimen Handling (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Bevacizumab (1) · Cisplatin (1) · Conservative Treatment (1) · Defecation (1) · Docetaxel (1) · Doxorubicin (1)
National Cancer Institute (NCI) (3) · Henan Cancer Hospital (2) · NiKang Therapeutics, Inc. (2) · Peking University (2) · AHS Cancer Control Alberta (1) · Asan Medical Center (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Eli Lilly and Company (1) · Fujian Medical University (1) · Hospices Civils de Lyon (1) · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1) · Lin Chen (1) · Mayo Clinic (1) · Nanjing Sike Pharmaceutical Co., Ltd. (1)
China (13) · United States (6) · Canada (2) · South Korea (2) · Bangladesh (1) · France (1) · Italy (1) · Lithuania (1) · Ukraine (1)
Hatim Karachiwala, MD (1) · Jiafu Ji, M.D. (1) · Jieer Ying, Doctor (1) · Jin Li, Dr. (1) · Jing Sun, PhD (1) · Kanwal P Raghav (1) · Li Yu, Dr (1) · Liza C Villaruz (1) · Mamta Parikh (1) · Mykyta Pepenin, MD (1) · Quanli Gao, Dr (1) · Roxana S. Dronca, MD (1) · Sarwar Alam, MBBS, Mphil (1)
PMID 12168979, PMID 15051021, PMID 16822992, PMID 17708549, PMID 20706861, PMID 27008576, PMID 28126704, PMID 29472484, PMID 29768387, PMID 30460342, PMID 31262598, PMID 31897343, PMID 32060757, PMID 33734139, PMID 34252374, PMID 34523717, PMID 35938363, PMID 39841295, PMID 39952264, PMID 7551332
UM1CA186688 (1), UM1CA186690 (1), UM1CA186717 (1)